Page 142 - 南京医科大学学报自然科学版
P. 142

第43卷第10期
               ·1468 ·                           南 京    医 科 大 学 学         报                        2023年10月


              的探索则较少,这也是未来研究需要重点关注的方                                 E:advancing research and patient care[J]. J Hepatol,
              向之一。                                                   2022,77(4):1109-1123
                  戊型肝炎重症化和慢性化结局是 HEV 和多因                        [14] KAMAR N,GARROUSTE C,HAAGSMA E B,et al. Fac⁃
              素共同作用的结果,其中免疫反应在病毒感染、炎                                 tors associated with chronic hepatitis in patients with hepa⁃
                                                                     titis E virus infection who have received solid organ
              症反应及疾病进展中扮演重要角色,深入系统探究
                                                                     transplants[J]. Gastroenterology,2011,140(5):1481-1489
              其免疫学机制有望为寻找特异有效的早期诊断和
                                                                [15] BUESCHER G,OZGA A K,LORENZ E,et al. Hepatitis
              防治策略提供重要线索和科学依据。
                                                                     E seroprevalence and viremia rate in immunocompro⁃
             [参考文献]                                                  mised patients:a systematic review and meta⁃analysis[J].
                                                                     Liver Int,2021,41(3):449-455
             [1] NAIR V P,ANANG S,SUBRAMANI C,et al. Endoplas⁃
                                                                [16] EVAVOLD C L ,KAGAN J C. How inflammasomes
                   mic reticulum stress induced synthesis of a novel viral fac⁃
                                                                     inform adaptive immunity[J]. J Mol Biol,2018,430(2):
                   tor mediates efficient replication of genotype⁃ 1 hepatitis
                                                                     217-237
                   E virus[J]. PLoS Pathog,2016,12(4):e1005521
                                                                [17] KUPKE P,WERNER J M. Hepatitis E virus infection⁃
             [2] VELAVAN T P,PALLERLA S R,JOHNE R,et al. Hepa⁃
                                                                     immune responses to an underestimated global threat[J].
                   titis E:an update on one health and clinical medicine[J].
                                                                     Cells,2021,10(9):2281
                   Liver Int,2021,41(7):1462-1473
                                                                [18] WU J,HUANG F,LING Z X,et al. Altered faecal micro⁃
             [3] LI P,LIU J,LI Y,et al. The global epidemiology of hepati⁃
                                                                     biota on the expression of Th cells responses in the exac⁃
                   tis E virus infection:a systematic review and meta⁃analy⁃
                                                                     erbation of patients with hepatitis E infection[J]. J Viral
                   sis[J]. Liver Int,2020,40(7):1516-1528
             [4] 中华人民共和国国家卫生健康委员会. 国家疾控局发                            Hepat,2020,27(11):1243-1252
                                                                [19] 李   岩,杨   勇. NK 细胞在肝脏疾病中的作用机制研
                   布 2022 年 8 月全国法定传染病疫情概况[EB/OL].
                  (2022-09-30)[2023⁃03⁃21]. http://www.nhc.gov.cn/xcs/  究进展[J]. 药学研究,2019,38(6):348-350,354
                                                                [20] SRIVASTAVA R,AGGARWAL R,BHAGAT M R,et al.
                   fkdt/202209/3aa12c2c369a436e856d1340a54d92e8.shtml
             [5] 中华医学会肝病学分会. 戊型肝炎防治共识[J]. 中华                         Alterations in natural killer cells and natural killer T
                                                                     cells during acute viral hepatitis E[J]. J Viral Hepat,
                   肝脏病杂志,2022,30(8):820-831
             [6] NIMGAONKAR I,DING Q,SCHWARTZ R E,et al.             2008,15(12):910-916
                                                                [21] 李   丽. 急性戊型肝炎病毒感染后 NK 和 NKT 细胞的
                   Hepatitis E virus:advances and challenges[J]. Nat Rev
                   Gastroenterol Hepatol,2018,15(2):96-110           作用及相关机制研究[D]. 南京:东南大学,2013
             [7] SEDHOM D,D'SOUZA M,JOHN E,et al. Viral hepatitis  [22] PRABHU S B,GUPTA P,DURGAPAL H,et al. Study of
                   and acute liver failure:still a problem[J]. Clin Liver Dis,  cellular immune response against Hepatitis E virus
                   2018,22(2):289-300                               (HEV)[J]. J Viral Hepat,2011,18(8):587-594
             [8] PATTERSON J,HUSSEY H S,SILAL S,et al. Systematic  [23] MEDEL M L H,REYES G G,PORRAS L M,et al. Prolac⁃
                   review of the global epidemiology of viral⁃induced acute  tin induces IL⁃2 associated TRAIL expression on natural
                   liver failure[J]. BMJ Open,2020,10(7):e037473     killer cells from chronic hepatitis C patients in vivo and in
             [9] TERESA PÉREZ⁃GRACIA M,SUAY⁃GARCÍA B,MA⁃             vitro[J]. Endocr Metab Immune Disord Drug Targets,
                   TEOS ⁃ LINDEMANN M L. Hepatitis E and pregnancy:  2019,19(7):975-984
                   current state[J]. Rev Med Virol,2017,27(3):e1929  [24] ZUO W,ZHAO X Y. Natural killer cells play an impor⁃
             [10] QIU L X,HUANG Y,QUAN J L,et al. Prognosis of hepa⁃  tant role in virus infection control:antiviral mechanism,
                   titis E infection in patients with chronic liver disease:a  subset expansion and clinical application[J]. Clin Immu⁃
                   meta⁃analysis[J]. J Viral Hepat,2023,30(2):101-107  nol Orlando Fla,2021,227:108727
             [11] GUERRA J A A A,KAMPA K C,MORSOLETTO D G B,    [25] ABRAVANEL F,BARRAGUÉ H,DÖRR G,et al. Con⁃
                   et al. Hepatitis E:a literature review[J]. J Clin Transl  ventional and innate lymphocytes response at the acute
                   Hepatol,2017,5(4):376-383                         phase of HEV infection in transplanted patients[J]. J
             [12] WESTHÖLTER D,HILLER J,DENZER U,et al. HEV⁃         Infect,2016,72(6):723-730
                   positive blood donations represent a relevant infection  [26] LHOMME S,MIGUERES M,ABRAVANEL F,et al.
                   risk for immunosuppressed recipients[J]. J Hepatol,  Hepatitis E virus:how it escapes host innate immunity
                   2018,69(1):36-42                                 [J]. Vaccines(Basel),2020,8(3):422
             [13] MA Z,DE MAN R A,KAMAR N,et al. Chronic hepatitis  [27] 李晓领,张  青,王李安,等. 戊型肝炎病毒感染的免疫
   137   138   139   140   141   142   143   144   145   146   147